Correction to "In Vitro and In Vivo Comparison of Random versus Site-Specific Conjugation of Bifunctional Chelating Agents to the CD33-Binding Antibody for Use in Alpha- and Beta-Radioimmunotherapy". [PDF]
Allen KJH +7 more
europepmc +1 more source
Editorial: Development and validation of new molecular probes of nuclear medicine and new targets of nuclear drugs in cancers. [PDF]
Li W, Wang Z, Chen X, Qin Y, Dai D.
europepmc +1 more source
Heteroresistance to amikacin in <i>Klebsiella aerogenes</i> isolates from patients in an intensive care unit in Brazil. [PDF]
Crispim NR +13 more
europepmc +1 more source
Self-care practices of professionals on residency programs in the state of Paraíba in Brazil and their implications for primary health care. [PDF]
Machado APR +11 more
europepmc +1 more source
[<sup>18</sup>F]MNI-1054, a novel PET ligand for lysine-specific histone demethylase 1 A (LSD1): first-in human validation and enzyme occupancy of the LSD1 inhibitor TAK-418. [PDF]
Schwarz AJ +10 more
europepmc +1 more source
CXCR4-targeted PET imaging of glioblastoma using [<sup>68</sup>Ga]Ga-TD-01: from pharmacokinetics and dosimetry to theranostic potential. [PDF]
Suwattananuruk P +9 more
europepmc +1 more source
S-values for bone marrow dosimetry in preclinical radiopharmaceutical studies with rodents. [PDF]
Obaid M +4 more
europepmc +1 more source
Estimation of the delay for resumption of breastfeeding after 131-iodine therapy by milk radioactivity measurement. [PDF]
Chaib S +6 more
europepmc +1 more source
Theranostic Potential of <sup>177</sup>Lu-TLX591 with Best Standard-of-Care and <sup>68</sup>Ga-PSMA-11 PET for Patients with Metastatic Castration-Resistant Prostate Cancer: Results from the Phase 1 ProstACT SELECT Trial. [PDF]
Lenzo N +5 more
europepmc +1 more source

